BioAffinity Technologies Inc [NASDAQ: BIAF] stock went on an upward path that rose over 5.92% on Friday, amounting to a one-week price increase of more than 12.97%.
Over the last 12 months, BIAF stock dropped by -70.33%. The one-year BioAffinity Technologies Inc stock forecast points to a potential upside of 95.5. The average equity rating for BIAF stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $7.98 million, with 28.46 million shares outstanding and 21.45 million shares in the current float. Compared to the average trading volume of 4.39M shares, BIAF stock reached a trading volume of 20665111 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on BioAffinity Technologies Inc [BIAF]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIAF shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIAF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BIAF Stock Performance Analysis:
BioAffinity Technologies Inc [BIAF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.97. With this latest performance, BIAF shares dropped by -3.57% in over the last four-week period, additionally sinking by -23.81% over the last 6 months – not to mention a drop of -70.33% in the past year of trading.
Insight into BioAffinity Technologies Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and BioAffinity Technologies Inc [BIAF] shares currently have an operating margin of -131.01% and a Gross Margin at 22.41%. BioAffinity Technologies Inc’s Net Margin is presently recorded at -152.18%.
BioAffinity Technologies Inc (BIAF) Capital Structure & Debt Analysis
BioAffinity Technologies Inc (BIAF) Efficiency & Liquidity Metrics
BioAffinity Technologies Inc (BIAF) Efficiency & Liquidity Metrics
From an operational efficiency perspective, BioAffinity Technologies Inc. (BIAF) effectively leverages its workforce, generating an average of -$205087.72 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.64% and a Quick Ratio of 0.63%, indicating strong ability to cover short-term liabilities.
BIAF Stock EPS
With the latest financial reports released by the company, BioAffinity Technologies Inc posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BIAF.
BioAffinity Technologies Inc [BIAF] Institutonal Ownership Details
There are presently around $1.46%, or 1.80%% of BIAF stock, in the hands of institutional investors. The top three institutional holders of BIAF stocks are: VANGUARD GROUP INC with ownership of 0.17 million shares, which is approximately 1.5101%. GEODE CAPITAL MANAGEMENT, LLC, holding 69600.0 shares of the stock with an approximate value of $$0.15 million in BIAF stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$60232.0 in BIAF stock with ownership which is approximately 0.2448%.
